Participation of the central serotonergic pathway in the endotoxin-stimulated hypothalamo-pituitary-adrenal axis function

Medicina

Volumn 57, Issue 4, 1997, Pages 441-444

  Giovambattista, Andres ^a,b   Chisari, Andrea N ^a   Spinedi, Eduardo ^a  

^a Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^b Instituto Multidisciplinario de Biologia Celular   (Argentina)

Author keywords

ACTH; CRH; glucocorticoid; PCPA; serotonin; vasopressin

Indexed keywords

ARGIPRESSIN; ENDOTOXIN; FENCLONINE; LIPOPOLYSACCHARIDE; SEROTONIN;

ANIMAL EXPERIMENT; ARTICLE; HYPOGLYCEMIA; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; NONHUMAN; RAT; SEROTONINERGIC SYSTEM;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; ENDOTOXINS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; PITUITARY-ADRENAL SYSTEM; RATS; RATS, INBRED F344; SEROTONIN; VASOPRESSINS;

EID: 0030850404     PISSN: 00257680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Besedovsky HO, Del Rey A. Immune-neuro-endocrine interactions. facts and hypotheses. Endocr Rev 1996; 17. 64-102.
2. Munck A, Guyre PM, Holbrook, NJ. Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocr Rev 1984; 5: 25-44.
3. Fauci AS. Immunosuppressive and anti-inflammatory effects of glucocorticoids. In: Baxter JD, Rosseau GG, (eds). Glucocorticoid hormone action. New York: Springer, 1979; 449.
4. Sharp BM, Matta SG, Peterson PK, et al. Tumor necrosis factor is a potent ACTH secretagogue: comparison to interleukin-1. Endocrinology 1989; 124: 3131-3.
5. Dinarello CA, Mier JW. Lymphokines. N Engl J Med 1987; 317: 940-5.
6. Dinarello CA. The biology of interleukin-1. FASEB J 1988; 2: 108-15.
7. Fuller RW. The involvement of serotonin in regulation of pituitary-adrenocortical function. Front Neuroendocrinol 1992; 13: 250-70.
8. Fuller RW. Serotonergic stimulation of pituitary-adrenocortical function in rats. Neuroendocrinology 1981; 32: 118-27.
9. Spinedi E, Giacomini M, Jacquier MC, Gaillard RC. Changes in the hypothalamo-pituitary-adrenal axys after bilateral adrenalectomy: evidence for a median eminence site of glucocorticoid action. Neuroendocrinology 1991 ; 53: 160-70.
10. Hodgkinson SC, Allolio B, Landon J, Lowry PJ. Development of a non-extracted two-site immunoradiometric assay for corticotropin utilizing extreme amino- and carboxy-terminally directed antibodies. Biochem J 1984; 218: 703-11.
11. Zar JH. Biostatistical Analysis. Englewood Cliffs: Prentice-Hall, New Jersey, 1974.
12. Spinedi E, Gaillard RC. Stimulation of the hypothalamo-pituitary-adrenocortical axis by the central serotonergic pathway; involvement of endogenous corticotropin-releasing hormone but no vasopressin. J Endocrinol Invest 1991 ; 14: 551-7.
13. Aguilera G: Regulation of pituitary ACTH secretion during chronic stress. Front Neuroendocrinol 1994; 15: 321-50.
14. Jard S, Gaillard RC, Guillon G, et al. Vasopressin antagonists allow demonstration of a novel type of vasopressin receptor in the rat adenohypohpysis. Mol Pharmacol 1986; 30: 171-7.
15. Sawchenko PE, Imaki T, Potter E, et al. The functional anatomy of corticotropin releasing factor; Corticotropin Releasing Factor. In: Chadwick DJ, Marsh J, Akrill K, (eds). Ciba Foundation Symp 172. New York; Wiley and Sons, 1989; 5-26.